Scynexis, a provider of drug discovery and development solutions, has licensed its HEOS SaaS software platform for drug discovery to TB Alliance to accelerate tuberculosis (TB) research activities.
Subscribe to our email newsletter
HEOS is a drug research information management software platform that provides a secure, user-friendly data handling system and allows collaborators to view results and make informed decisions.
Powered by Accelrys tools including Accord data cartridge and Pipeline Pilot, HEOS supports geographically distributed scientists and facilitates collaboration.
Scynexis president and CEO Yves Ribeill said HEOS has become the standard collaborative research software platform in the Global Health area.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.